Literature DB >> 17259398

Genetic reconstitution of autoimmune type 1 diabetes with two major susceptibility genes in the rat.

Norihide Yokoi1, Chihiro Hayashi, Yuuka Fujiwara, He-Yao Wang, Susumu Seino.   

Abstract

The Komeda diabetes-prone (KDP) rat is an animal model of human autoimmune type 1 diabetes. We have previously shown that two major susceptibility genes, the major histocompatibility complex (MHC) RT1(u) haplotype and Cblb (Casitas B-lineage lymphoma b) mutation, are responsible for the development of diabetes in KDP rats, suggesting a two-gene model for development of the disease. To confirm the two-gene model, we produced a congenic strain carrying mutated Cblb alleles of the KDP rat on a non-KDP genetic background harboring the RT1(u) haplotype on its MHC. Despite the low incidence and delayed onset of diabetes, the congenic strain did develop the disease, indicating that type 1 diabetes can be reconstituted on a non-KDP genetic background with the RT1(u) haplotype and Cblb mutation. Similar to observations in KDP rats, the congenic strain showed insulitis and thyroiditis, symptoms of autoimmunity. The low incidence and delayed onset of the disease strongly suggest involvement of genetic modifiers; the congenic strain established in this study should be useful for the mapping and identification of such modifiers.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17259398     DOI: 10.2337/db06-1027

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  11 in total

1.  T-cell regulation by casitas B-lineage lymphoma (Cblb) is a critical failsafe against autoimmune disease due to autoimmune regulator (Aire) deficiency.

Authors:  Charis E Teh; Stephen R Daley; Anselm Enders; Christopher C Goodnow
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-28       Impact factor: 11.205

Review 2.  E3 ubiquitin ligase Cbl-b in innate and adaptive immunity.

Authors:  Qingjun Liu; Hong Zhou; Wallace Y Langdon; Jian Zhang
Journal:  Cell Cycle       Date:  2014-05-14       Impact factor: 4.534

3.  Genetic and phenotypic characterization of a Japanese wild-derived DOB/Oda rat strain.

Authors:  Takashi Kuramoto; Satoko Inoue; Yuki Neoda; Ken-ichi Yamasaki; Ryoko Hashimoto; Tomoji Mashimo; Sen-ichi Oda; Tadao Serikawa
Journal:  Mamm Genome       Date:  2013-07-30       Impact factor: 2.957

Review 4.  Protein tyrosine kinase regulation by ubiquitination: critical roles of Cbl-family ubiquitin ligases.

Authors:  Bhopal Mohapatra; Gulzar Ahmad; Scott Nadeau; Neha Zutshi; Wei An; Sarah Scheffe; Lin Dong; Dan Feng; Benjamin Goetz; Priyanka Arya; Tameka A Bailey; Nicholas Palermo; Gloria E O Borgstahl; Amarnath Natarajan; Srikumar M Raja; Mayumi Naramura; Vimla Band; Hamid Band
Journal:  Biochim Biophys Acta       Date:  2012-10-17

5.  Intrapatient variations in type 1 diabetes-specific iPS cell differentiation into insulin-producing cells.

Authors:  Tayaramma Thatava; Yogish C Kudva; Ramakrishna Edukulla; Karen Squillace; Josep Genebriera De Lamo; Yulia Krotova Khan; Toshie Sakuma; Seiga Ohmine; Andre Terzic; Yasuhiro Ikeda
Journal:  Mol Ther       Date:  2012-11-27       Impact factor: 11.454

6.  Role of major histocompatibility complex class II in the development of autoimmune type 1 diabetes and thyroiditis in rats.

Authors:  N Yokoi; S Hidaka; S Tanabe; M Ohya; M Ishima; Y Takagi; N Masui; S Seino
Journal:  Genes Immun       Date:  2011-09-15       Impact factor: 2.676

Review 7.  E3 ubiquitin ligase Casitas B lineage lymphoma-b and its potential therapeutic implications for immunotherapy.

Authors:  D Jafari; M J Mousavi; S Keshavarz Shahbaz; L Jafarzadeh; S Tahmasebi; J Spoor; A Esmaeilzadeh
Journal:  Clin Exp Immunol       Date:  2021-01-10       Impact factor: 5.732

Review 8.  Involvement of Cbl-b-mediated macrophage inactivation in insulin resistance.

Authors:  Tomoki Abe; Katsuya Hirasaka; Takeshi Nikawa
Journal:  World J Diabetes       Date:  2017-03-15

Review 9.  Current status and patent prospective of animal models in diabetic research.

Authors:  Radhey S Dhuria; Gurpreet Singh; Anudeep Kaur; Ramandeep Kaur; Tanurajvir Kaur
Journal:  Adv Biomed Res       Date:  2015-05-29

10.  Identification of Potential Therapeutic Targets in the Liver of Pioglitazone-Treated Type 2 Diabetes Sprague-Dawley Rats via Expression Profile Chip and iTRAQ Assay.

Authors:  Zhong-Xia Lu; Wen-Jun Xu; Yang-Sheng Wu; Chang-Yu Li; Yi-Tao Chen
Journal:  J Diabetes Res       Date:  2018-03-18       Impact factor: 4.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.